| 摘要 |
<p>The blanking periods for an implantable cardiac device, such as a pacemaker (10), is determined by providing an excitation in a cardiac chamber and monitoring the corresponding cardiac activity. For in-channel blanking periods, the response from the same chamber is monitored while for cross-channel blanking period, the other cardiac chamber is monitored. The optimal blanking period is then determined based on the cardiac activity. This period is programmed directly into the device, or transmitted to an external programmer (22) where it is used to provide guidance to a health care professional. The optimal blanking period duration may also be determined using other signals sensed by the programmer (22), using ECG's or MTE's.</p> |
